<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/Newsletter/style.css"/>
<title>HOLX vs. TMO: Which Diagnostic Giant Is the Stronger Buy Today? — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/Newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">HOLX vs. TMO: Which Diagnostic Giant Is the Stronger Buy Today?</h2>
    <div class="badge">2025-09-22T13:24:00+00:00</div>
    <ul>
      <li>Zacks Investment Research Image Source: Zacks Investment Research The Zacks Consensus Estimate for Hologic’s fiscal 2025 EPS implies year-over-year growth of 3.7% to $4.23.</li>
<li>Zacks Investment Research Image Source: Zacks Investment Research Meanwhile, the consensus mark for Thermo Fisher’s 2025 EPS of $22.52 has edged up 0.8% in the past 60 days.</li>
<li>The estimate indicates a 3% improvement over 2024.</li>
<li>In the last six months, HOLX shares have gained 4.2%, outpacing Thermo Fisher stock’s 7.7% fall.</li>
<li>Over the past 60 days, the estimate has increased 0.7%.</li>
<li>As of June 28, 2025, Thermo Fisher had $6.39 billion in cash and short-term investments against a short-term debt of $2.21 billion.</li>
<li>It is on the path to return to growth in the fourth quarter of fiscal 2025.</li>
    </ul>
    <p>
      <a class="btn" href="https://x.com/intent/tweet?text=HOLX%20vs.%20TMO%3A%20Which%20Diagnostic%20Giant%20Is%20the%20Stronger%20Buy%20Today%3F%0A%E2%80%A2%20Zacks%20Investment%20Research%20Image%20Source%3A%20Zacks%20Investment%20Research%20The%20Zacks%20Consensus%20Estimate%20for%20Hologic%E2%80%99s%20fiscal%202025%20EPS%20implies%20year-over-year%20growth%20of%203.7%25%20to%20%244.23.%0A%E2%80%A2%20Zacks%20Investment%20Research%20Image%20Source%3A%20Zacks%20Investment%20Research%20Meanwhile%2C%20the%20consensus%20mark%20for%20Thermo%20Fisher%E2%80%99s%202025%20EPS%20of%20%2422.52%20has%20edged%20up%200.8%25%20in%20the%20past%2060%20days.%0A%E2%80%A2%20The%20estimate%20indicates%20a%203%25%20improvement%20over%202024.%0A%E2%80%A2%20In%20the%20last%20six%20months%2C%20HOLX%20shares%20have%20gained%204.2%25%2C%20outpacing%20Thermo%20Fisher%20stock%E2%80%99s%207.7%25%20fall.%0A%E2%80%A2%20Over%20the%20past%2060%20days%2C%20the%20estimate%20has%20increased%200.7%25.%0A%E2%80%A2%20As%20of%20June%2028%2C%202025%2C%20Thermo%20Fisher%20had%20%246.39%20billion%20in%20cash%20and%20short-term%20investments%20against%20a%20short-term%20debt%20of%20%242.21%20billion.%0A%E2%80%A2%20It%20is%20on%20the%20path%20to%20return%20to%20growth%20in%20the%20fourth%20quarter%20of%20fiscal%202025.&url=https%3A%2F%2Fsuavir600.github.io%2FNewsletter%2Farticles%2Fholx-vs-tmo-which-diagnostic-giant-is-the-stronger-buy-today%2F" target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a class="btn" href="https://finance.yahoo.com/news/holx-vs-tmo-diagnostic-giant-132400988.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>